Delivery Order SPE2DR25D3109-SPE2DR26FT3FP
Award Date 5/5/26
Potential Completion Date 5/27/26
Potential Value $8.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $32,981.88 delivery order to AmerisourceBergen Drug Corp on May 1, 2026, for 9 milligram ITOVEBI tablets (28-count), firm fixed-price, with an ultimate completion date of May 22, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries no set-aside designation.</p>
- The Defense Logistics Agency issued a $16,478.14 delivery order to AmerisourceBergen Drug Corp on April 14, 2026, for ITOVEBI 3 MG tablets (28-count package), with an ultimate completion date of May 5, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside applied. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and supplies pharmaceutical products and medical commodities to federal agencies through its federal...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for ITOVEBI 3 mg tablets (28-count package) with a ceiling value of $16,478.14 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA 19428. Ultimate completion date is March 10, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $16,478.14 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for supply of Itovebi 3 mg tablets (28-count).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of April 2, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a $16,490.94 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for supply of Itovebi 9 mg tablets (28-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026, which provides pharmaceutical and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 16,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, with a ceiling value of $16,478.14 for supply of Itovebi 3 mg tablets (28 count). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that provides pharmaceutical and medical supply support to military healthcare systems globally. Place of performance is Conshohocken, PA. The order carries firm fixed pricing...
- The Defense Logistics Agency awarded a delivery order valued at $15,714.54 to AmerisourceBergen Drug Corp for ITOVEBI 3 MG tablets (28-count supply) on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single fulfillment under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,714.54 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Itovebi 3 mg tablets (28-count packaging) with a completion date of September 22, 2025. This firm fixed-price contract carries no set-aside designation and represents a competitive award to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,714.54 to AmerisourceBergen Drug Corp for Itovebi 3 mg tablets (28-count units) under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of October 3, 2025. The contract represents a non-competitive delivery order with no set-aside designation, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,222.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ITOVEBI 9 MG tablets (28-count packages) on November 18, 2025, with completion scheduled for December 10, 2025. This competitive award, with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT3FPDelivery Order
The Defense Logistics Agency issued a $8,239.06 delivery order to Amerisourcebergen Drug Corp on May 5, 2026, for ITOVEBI 3 mg tablets (28-count package), with ultimate completion on May 27, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. This is a transactional pharmaceutical delivery order under DLA's standing medical supply vehicle, consistent with Amerisourcebergen's role as a primary pharmaceutical distributor to federal defense healthcare systems.
Generated 8/3/26, 10:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 5/4/26 |